Examination about the pharmacokinetics of the dexamethasone under the Fosaprepitant medication to the nausea and vomiting of a high emetic risk chemotherapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Fosaprepitant (Primary) ; Dexamethasone; Palonosetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- Acronyms PROEMEND PK
- 24 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Jul 2014 New trial record